[A new generation of immunotherapies targeting the CD39/CD73/adenosine pathway to promote the anti-tumor immune response]

Med Sci (Paris). 2020 Feb;36(2):112-115. doi: 10.1051/medsci/2020006. Epub 2020 Mar 4.
[Article in French]
No abstract available

Publication types

  • News

MeSH terms

  • 5'-Nucleotidase / antagonists & inhibitors
  • 5'-Nucleotidase / immunology
  • 5'-Nucleotidase / metabolism*
  • Adaptive Immunity / physiology*
  • Adenosine / analogs & derivatives
  • Adenosine / antagonists & inhibitors
  • Adenosine / immunology
  • Adenosine / metabolism*
  • Antigens, CD / immunology
  • Antigens, CD / metabolism*
  • Apyrase / antagonists & inhibitors
  • Apyrase / immunology
  • Apyrase / metabolism*
  • Humans
  • Immunotherapy / methods
  • Immunotherapy / trends*
  • Molecular Targeted Therapy / methods
  • Molecular Targeted Therapy / trends
  • Neoplasms / immunology
  • Neoplasms / therapy*
  • Signal Transduction / immunology

Substances

  • Antigens, CD
  • 5'-Nucleotidase
  • Apyrase
  • CD39 antigen
  • Adenosine